Clinical Evidence and Practice-Based Guidelines on the Utility of Basal insulin combined Oral therapy (metformin and glimepiride) in the current era.
Abhishek ShrivastavaJothydev KesavadevViswanathan MohanBanshi SabooDina ShresthaAnuj MaheshwariBrij Mohan MakkarKirtikumar D ModiAshok Kumar DasPublished in: Current diabetes reviews (2023)
These current clinical practice guidelines highlight the efficacy and safety of basal insulin combination therapy with various available basal insulins including neutral protamine hagedorn, detemir, glargine and degludec in addition to metformin and glimepiride therapy.